Closing Bell: Nervgen Pharma Corp down on Friday (NGEN)

Today during trading, Nervgen Pharma Corp shares closed at $2.84 after opening the day at $2.95. It traded at a low of $2.79 to a high of $2.95.

Shares decreased -4.70 percent from the previous day's close of $2.98.

During the day across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -1.84% at 5346.56, the Dow Jones Industrial Average closed -1.51% at 39737.26 and the Nasdaq Composite closed -2.43% at 16776.16.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

Trading volume was 64,160 on 174 total trades, with an average volume of 43,254 over the last 5 days.

Trading across the entire TSX-V saw 432 price advancers against 4,843 declines and 43 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, in the last 52 weeks, Nervgen Pharma Corp's shares have soared 67.06 percent, while they have advanced 5.19% since the start of 2024.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $198.59 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Based on 0.00 analysts, Nervgen Pharma Corp gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..